New Edge Wealth, LLC Regeneron Pharmaceuticals, Inc. Transaction History

New Edge Wealth, LLC

$4.55 Billion
Q1 2024

A detailed history of New Edge Wealth, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, New Edge Wealth, LLC holds 36,260 shares of REGN stock, worth $37.5 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

36,260

Previous 32,719 10.82%

Holding current value

$37.5 Million

Previous $28.7 Million 21.45%

% of portfolio

0.77%

Previous 0.76%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$902.69 - $993.35 $3.2 Million - $3.52 Million	3,541 Added 10.82%	36,260 $34.9 Million
Q4 2023 Jan 29, 2024	BUY	$775.18 - $881.7 $3.32 Million - $3.78 Million	4,287 Added 15.08%	32,719 $28.7 Million
Q3 2023 Nov 08, 2023	BUY	$692.45 - $844.37 $4.92 Million - $5.99 Million	7,099 Added 33.28%	28,432 $23.4 Million
Q2 2023 Aug 09, 2023	BUY	$700.03 - $830.35 $515,922 - $611,967	737 Added 3.58%	21,333 $15.3 Million
Q1 2023 May 08, 2023	BUY	$680.49 - $826.97 $668,921 - $812,911	983 Added 5.01%	20,596 $16.9 Million

Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $617,653 - $670,591	875 Added 4.67%	19,613 $14.2 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $1.07 Million - $1.35 Million	1,864 Added 11.05%	18,738 $12.9 Million
Q2 2022 Aug 09, 2022	BUY	$548.35 - $738.84 $313,107 - $421,877	571 Added 3.5%	16,874 $9.98 Million
Q1 2022 May 10, 2022	BUY	$595.12 - $698.43 $4.16 Million - $4.88 Million	6,989 Added 75.04%	16,303 $11.4 Million
Q4 2021 Jan 31, 2022	BUY	$543.48 - $670.97 $5.06 Million - $6.25 Million	9,314 New	9,314 $5.88 Million
Q2 2021 Aug 11, 2021	SELL	$472.8 - $558.54 $561,686 - $663,545	-1,188 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $530,715 - $651,261	1,188 New	1,188 $562,000

Others Institutions Holding REGN

# of Institutions

1,427

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $111B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.

Account

New Edge Wealth, LLC Regeneron Pharmaceuticals, Inc. Transaction History